Guangdong Ruitai Pharmaceuticals Files IPO Application with Hong Kong Stock Exchange on May 22

GateNews
According to Hong Kong Exchanges and Clearing filings, Guangdong Ruitai Pharmaceuticals Co., Ltd. submitted its IPO application to the Hong Kong Stock Exchange on May 22. CITIC Securities is the sole sponsor for the listing.
Disclaimer: The information on this page may come from third-party sources and is for reference only. It does not represent the views or opinions of Gate and does not constitute any financial, investment, or legal advice. Virtual asset trading involves high risk. Please do not rely solely on the information on this page when making decisions. For details, see the Disclaimer.
Comment
0/400
No comments